1
Transcription is a highly dynamic process that comprises three different stages. Initiation 2 involves RNA Polymerase II recruitment to the promoter followed by release of RNA Pol II 3 towards progressive elongation. Transcriptional termination is promoted when RNA transcripts 4 are processed and RNA Pol II is released from the chromatin template (Harlen and 5
Churchman, 2017; Jonkers and Lis, 2015) . This dynamic shift from one stage to another is 6 facilitated by a compendium of regulatory processes involving phosphorylation of the Pol II C-7
terminal domain (CTD) and recruitment of factors that facilitate and regulate RNA Pol II activity 8 (Bentley, 2014; Jeronimo et al., 2015; Voss and Hager, 2013) . 9
Approaches that precisely map the position of RNA Pol II at a high resolution have provided a . Immunoprecipitation has a potential 20 second benefit as it would allow in principle the interrogation of transcription factor -RNA Pol 21 II interaction genome-wide quantitatively, at nucleotide resolution and strand-specificity, none 22 of which is possible using conventional ChIP-seq. In S. cerevisiae, such an approach -coined 23 TEF-seq -was developed to interrogate Paf1 -RNA Pol II interaction (Fischl et al., 2017) and 24 allowed new insight into Paf1 requirements for gene expression. 25
Here, we sought to develop a mammalian counterpart to TEF-seq, which includes an 26 immunoprecipitation step of RNA Pol II associated factors, while being efficient enough to 27 capture sufficient amounts of nascent RNA for processing the latter as part of NET-seq type 28 libraries. A detailed protocol is outlined in Figure 1A and also in a step-by-step form as part of 29 the Supplementary Information ("NET-prism protocol"). Extraction conditions of NET-prism allow for co-purification of RNA Pol II with known 2 associated complex members 3 4 Similarly to the original yeast NET-seq and TEF-seq protocols (Churchman and Weissman, 5 2011; Fischl et al., 2017) , we relied on a strong inhibitor for Pol II (α-amanitin) to prevent run-6 on of the polymerase during all lysis steps and on DNase I to solubilize chromatin. We 7 optimized conditions for DNase I treatment in the absence and presence of urea, which proved 8 to be necessary for efficient solubilization. We found that 100U DNase I and 50mM urea were 9 sufficient to release a large fraction of engaged RNA Pol II from chromatin (Supplementary 10 Figure 1 ). We then wanted to investigate if we were able to IP known and new co-factors of 11
RNA Pol II under these experimental conditions and examined the total Pol II protein 12 interactome by Mass spectrometry using the same extraction conditions as NET-prism to 13 identify such factors in a native chromatin state. We identified both, positive (Supt5, Supt6, FACT, Paf1) and negative (NELF) elongation 1 factors as well as splicing (Srsf5, Srsf6, Sf1) and TFIID (Taf10, Taf15) components as 2 significantly enriched with Pol II under NET-prism conditions ( Figure 1B and Supplementary  3   Table 1) , equipping researchers with a list to guide any follow-up experimentation. We were 4 also able to confirm some of these interactions using immunoprecipitation followed by western 5 blotting ( Figure 1C ). 6 7 NET-prism captures unique transcriptional footprints of RNA Pol II-associated factors 8 9 We picked one transcription factor, TFIID (antibody raised against TBP) and two elongation 10 factors, Spt6 and Sssrp1 (subunit of the FACT heterodimer) to validate the NET-prism 11 approach and interrogate the impact of these factors on RNA Pol II activity. We also performed 12 an IP for Mediator (Med14), serving as a negative control, since it did not display a significant 13 association with Pol II under the conditions used to solubilise chromatin ( Figure 1C ). The data 14
were highly reproducible among biological replicates (Supplementary Figure 2A whereas an IP for Mediator (Med14) yields no nascent RNA transcripts as there is minimal 24 interaction between Mediator and RNA Pol II under the conditions used ( Figure 2A ). Similar 25 RNA Pol II patterns were also confirmed at a single gene level ( Figure 2B ). To test more 26 systematically how different transcription factors might influence RNA Pol II initiation and 27 elongation, we sought to determine whether different NET-prism libraries provide improved 28 resolution of RNA Pol II distribution patterns. We calculated the travelling ratio (TR) in the 29 sense direction which is defined as the density of RNA Pol II over the promoter (-30 to +250 30 bp around the TSS) versus the gene body area (+300 bp downstream of the TSS to -200 bp 31 upstream of the TES) . All NET-prism libraries exhibited different TRs indicating different 32 pause-release dynamics of Pol II when bound by different TFs ( Figure 2C ) These data suggest 33 that NET-prism is indeed able to resolve mechanistic and dynamic interplays between 34 transcription factors and active RNA Pol II. Nascent RNA transcripts upstream of the TSS 35 (sense direction) are too short to produce mappable sequencing reads as the minimum read 36 length is ~18 nt for unique alignment to the mammalian genome. Therefore, in order to 37 characterise Pol II distribution over those sites we specifically examined anti-sense 1 transcription and coined the "Reverse travelling ratio" which is defined as the density of 2 initiating divergent Pol II versus the density of elongating divergent Pol II (Supplementary 3 Figure 2C ). We observed different reverse travelling ratios for all TFs that are bound to RNA 4 Pol II further reinforcing the unique propensity of each TF in controlling anti-sense pause 5 release. Interestingly, as all three factors examined here (Spt6, SSRP1 and as TFIID antibody was 9 raised against TBP) also interact with RNA Pol I and III, we asked if nascent transcript would 10 also stem from gene products of these two polymerases. Indeed, all three IPs against these 11 proteins also pull-down nascent transcripts generated by RNA Pol I and Pol III (Supplementary 12 Figure 2D ), suggesting that NET-prism might be an ideal tool for the investigation of all three 1 RNA polymerases. 2 3 Sequential NET-prism confirms that nascent RNA stems from direct interaction 4 between active RNA Pol II and Ssrp1 5
Using western blotting, we showed that the conditions of NET-prism allow co-purification of 6 RNA Pol II in the IPs against transcription factors ( Figure 1C ). However, at least one of them, 7
Ssrp1 has been previously reported to bind RNA (Baltz et al., 2012; Beckmann et al., 2015; 8 He et al., 2016) . Therefore, we decided to test more rigorously if the recovered nascent RNA 9
is specifically associated with RNA Pol II and does not stem from direct binding of Ssrp1 to 10 nascent RNA. In order to address this question, we performed a sequential IP as part of NET-11 prism as outlined in Figure 3A . Initially, RNA Pol II was immunoprecipitated using an anti-CTD antibody, followed by 1 competitive elution of RNA Pol II by an excess of CTD peptide (the exact peptide used to 2 generate the a-CTD antibody). The eluent subsequently served as input for the second round 3 of IP using an anti-SSRP1 antibody to capture exclusively SSRP1-bound Pol II complexes. 4
The isolated nascent RNA was subsequently used for library generation. Importantly, 5
comparing single and sequential IP by metagene profiling ( Figure 3B ) and single gene 6 interrogation ( Figure 3C ) revealed high similarity, strongly suggesting that indeed, NET-prism 7 captures only nascent RNA bound by RNA polymerases and not by TFs. 8 9
NET-prism reveals high resolution Pol II pausing at intron-exon boundaries 10
Transcriptional elongation rates can affect splicing outcomes suggesting that transcription and 11 pausing at splice sites. We also reasoned that NET-prism might be an ideal tool to dissect 17 splicing factor -RNA Pol II interaction at splice sites. Therefore, we performed an additional 18
NET-prism library for Splicing factor 1 (Sf1) and included this in our splicing dynamics analysis. 19
As splicing intermediates are known NET-seq contaminants due to the presence of 3'-OH 20 Figure 4B ). Interesting to note is also the fact that NET-prism libraries 28 displayed higher Pol II density over exons as opposed to introns suggesting that transcriptional 29 elongation is slower at exons in mouse ES cells ( Figure 4B ,C). In addition, Sf1-PolII interaction 30 clearly marks exons, indicating specificity of the approach. Taken together, these results 31 augment the kinetic model of transcription and splicing coupling. Our data in combination with 32 previously published results therefore suggest that transcriptional splicing mechanics is 33 facilitated by Pol II variants and elongation factors differently and NET-prism might represent 34 one ideal tool to address this at high resolution. over enhancers as in promoters, in terms of initiation and elongation. We therefore extended 13 our analysis to identify high resolution Pol II footprints at distal and super-enhancers using 14 NET-prism transcriptional activity exposed distinctive topographic footprints; Ssrp1 displayed 7 patterns similar to transcriptional initiation whereas Spt6 imitated a trail reminiscent of 8 transcriptional elongation. Moreover, transcriptional activity prompted by TFIID also supports, 9
to some degree, a notion of transcriptional initiation over enhancers ( Figure 5C ). Here, we have developed a new approach to accurately assess transcriptional topography at 15 a high resolution. In summary, NET-prism allows the direct strand-specific investigation of the 16 transcriptional landscape at single nucleotide resolution of any protein of interest in complex 17 with RNA Pol II. Its robustness enables a deeper insight into the interplay of transcriptional 1 mechanisms conferred by different Pol II variants and proteins that are bound to Pol II. The 2 comprehensive Pol II -protein interactome that we provide here ( Supplementary Table 1 ) 3 facilitates the choice of the protein of interest when applying NET-prism. In addition, given the 4 right RNA polymerase inhibitors and antibodies, NET-prism can be extended to specifically 5 interrogate nascent transcription governed by either RNA Pol I or Pol III. 6
We hypothesize that NET-prism will be an ideal tool to investigate transcription/elongation 7 factor interactions with actively travelling RNA polymerase at single nucleotide resolution and 8 with strand specificity. An analogous approach has been previously developed in yeast (Fischl It is important to recognize though that NET-prism -similarly to ChIP-seq -greatly relies on 23 the quality of the antibody used. Antibody cross-reactivity might result in unspecific binding 24 and thus, generation of artefactual RNA Pol II footprints. Therefore, the choice of a highly 25 specific antibody for the protein of interest is important to achieve unique RNA Pol II footprints. implemented on all the above extraction steps for batches intended for Pol II S2ph and Pol II 33
S5ph immunoprecipitations. 34
Chromatin Immunoprecipitation (IP) and nascent RNA extraction. A detailed protocol is 1 available in the Supplementary Information ("NET-prism protocol"). Briefly, combined 2 supernatants from the previous step were incubated in a final 1/10 dilution in IP buffer for 2 3 hours at 4ºC. For the sequential IP, a total Pol II antibody was used for 2 hours, followed by 4 elution twice with 100 μl 2.5 mM CTD peptide (synthesized by Peptide Specialty Laboratories, 5
Heidelberg, Germany; identical to Abcam ab17564) for 30 min. The eluate was further 6 incubated with Ssrp1 antibody-coated beads for an additional 2 hours. Beads were washed 4 7 times with 1 ml of IP buffer and 700 μl of Qiazol (Qiagen) was directly added to the beads, with the TSS were assigned as 'sense' and 'anti-sense' tags, respectively. Promoter-proximal 7 regions were carefully selected for analysis to ensure that there is minimal contamination from 8 transcription arising from other transcription units. Genes overlapping within a region of 2.5 kb 9
upstream of the TSS were removed from the analysis. For the NET-seq/prism metaplots, 10 genes underwent several rounds of k-means clustering in order to filter regions; in a 2kb 11 window around the TSS, rows displaying very high Pol II occupancy within a <100 bp region 12
were removed from the analysis as they represent non-annotated short non-coding RNAs. For 13 were converted to mm10 using the LiftOver tool from UCSC and were further removed from 5 the analysis. Average binding profiles were visualised using R (v 3.3.0). 6
Mass spectrometry sample preparation. Independent ES cell cultures were grown in 10cm 7 dishes. Per IP, 20x10 7 cells were extracted, lysed, and nuclei were treated with DNase I as 8 described above. The supernatant was incubated for 2 hours with a total Pol II antibody (ab817 9 -Abcam) or IgG (Cell Signalling) at 4ºC. In total, four samples were prepared for each IP 10 analytical column (New Objective) packed with 1.9 μm ReproSil-Pur 120 C18-AQ media (Dr. 17
Maisch) using an EASY-nLC 1200 (Thermo Fisher Scientific). The column was maintained at 18 50°C. Buffer A and B were 0.1% formic acid in water and 0.1% formic acid in 80% acetonitrile. 19
Peptides were separated on a segmented gradient from 6% to 31% buffer B for 45 min and 20 from 31% to 50% buffer B for 5 min at 200 nl / min. Eluting peptides were analyzed on a 21
QExactive HF mass spectrometer (Thermo Fisher Scientific). Peptide precursor m/z 22 measurements were carried out at 60000 resolution in the 300 to 1800 m/z range. The top ten 23 most intense precursors with charge state from 2 to 7 only were selected for HCD 24 fragmentation using 25% normalized collision energy. The m/z values of the peptide fragments 25
were measured at a resolution of 30000 using a minimum AGC target of 8e3 and 55 ms 26 The digestion parameters were set to "specific" and "Trypsin/P," The minimum number of 35 peptides and razor peptides for protein identification was 1; the minimum number of unique 1 peptides was 0. Protein identification was performed at a peptide spectrum matches and 2 protein false discovery rate of 0.01. The "second peptide" option was on. Successful 3 identifications were transferred between the different raw files using the "Match between runs" 4 option. Label-free quantification (LFQ) (Cox et al., 2014) was performed using an LFQ 5 minimum ratio count of 2. LFQ intensities were filtered for at least three valid values in at least 6 one group and imputed from a normal distribution with a width of 0.3 and down shift of 1.8. 7
The median value of the log2 LFQ intensities for the RNA Pol II IPs was used for the imputation 8 Mayer, A., di Iulio, J., Maleri, S., Eser, U., Vierstra, J., Reynolds, A., Sandstrom, R., is between 500 -1000 ng/ µl. IPs for elongations factors (Spt6) yield large RNA fragments 7
(>2000 nt) whereas PIC components yield lower (< 200 nt). 8 42| Parse samples into the same NET-seq library as previously described (Mayer &  9 Churchman, 2016: Nature Protocols). Make the appropriate modifications as described 10
below to allow a more efficient adaptor ligation and material recovery after ligation and cDNA 11 synthesis. 12 13 14 -The random barcode was ligated overnight at 16 ºC to maximise ligation efficiency. Column (Zymo Research, C1007-50) and further precipitated for subsequent library 29 preparation steps. 30
